390) was conducted for 206 patients with colon cancer treated in 2005 and 2006 in the Net |
391) boratory data in patients with colorectal cancer treated with oxaliplatin-based chem |
392) ics that make it an attractive entity for cancer treatment and possible therapeutic |
393) er is one of the promising modalities for cancer treatment. |
394) between passive smoking and female breast cancer using meta-analysis. |
395) ity of radioiodine treatment for cervical cancer using the early growth response (Eg |
396) GEM in patients with resected pancreatic cancer were identified and the hazard rati |
397) All dogs with cancer were identified using a proprietary |
398) ith a 1.42-fold increased risk of bladder cancer (95% confidence interval [CI], 1.11 |
399) Bladder cancer (BC) is the fifth most common cance |
400) It is well known that non-small cell lung cancer (NSCLC) is a heterogeneous group of |
401) osis of patients with non-small cell lung cancer (NSCLC); however, the results of th |
402) e of p66Shc protein in regulating ovarian cancer (OCa) cell proliferation. |
403) re known to have higher rates of prostate cancer (PC) and some animal studies have i |
404) Hypoxic conditions in prostate cancer (PCA) are associated with poor prog |
405) esting for and managing men with prostate cancer (PCa) is significant. |
406) rvation study "Quality Assurance - Rectal Cancer" (at the Institute for Quality Assu |
407) nship between chewing betel quid and oral cancer (or precancer). |
408) distributed among persons diagnosed with cancer; 2,355 people responded. |
409) Intestinal organoids derived from cancer-prone Apc(Min/+) mice showed simila |
410) ve Buffering Scale, the Expanded Prostate Cancer Index Composite, the Sexual Experie |
411) arability of the Functional Assessment of Cancer Therapy General and Breast Cancer s |
412) nt allele had an increased risk of breast cancer [adjusted odd ratio (OR) = 1.37, |
413) entive agent, and possesses multiple anti-cancer activities including induction of a |
414) Prostate cancer affects couples' sexual intimacy, b |
415) xorubicin (DOX) is widely used as an anti-cancer agent although it causes irreversib |
416) ility of co-administrating LGFJ with anti-cancer agents to modulate multidrug resist |
417) n early onset and familial breast/ovarian cancer among Tunisian women. |
418) cohort of 37,411 patients diagnosed with cancer between 2000 and 2008 in Taiwan, co |
419) pose of evaluating their effect on breast cancer biology, o,p'-DDT, p,p'-DDE, and p, |
420) e the paradigm of inflammation-associated cancer by illuminating the key role of bac |
421) rods and wafers are increasingly used in cancer chemotherapy in order to enhance th |
422) = 131) of children with type 1 diabetes, cancer, congenital heart disease (CHD) and |
|